Systems and methods for organoid culture

The system addresses the challenges of growing and monitoring large organoids by using a receptacle with a sealing member and 3D printing for scaffold formation, enabling efficient culture and imaging without sectioning.

JP7595584B2Active Publication Date: 2024-12-06MOLECULAR DEVICES AUSTRIA GMBH
View PDF 2 Cites 0 Cited by

Patent Information

Application Number
JP2021565933
Authority / Receiving Office
JP · JP
Patent Type
Patents
Current Assignee / Owner
Priority Date
2019-05-08
Filing Date
2020-05-07
Publication Date
2024-12-06
Estimated Expiration
2040-05-07

AI Technical Summary

Technical Problem

Existing organoid culture systems face challenges in efficiently growing, monitoring, and analyzing large organoids due to the need for optimized matrix scaffolds, medium exchange, mechanical resistance, and imaging methods that require physical fixation and sectioning.

Method used

A system and method for culturing organoids using a receptacle with a sealing member to create a chamber, allowing for fluid introduction and imaging within the chamber, and incorporating 3D printing for scaffold formation and optical windows for monitoring.

Benefits of technology

Enables the growth and high-content, high-throughput monitoring of large organoids with optimized conditions, facilitating genome editing and imaging without physical sectioning.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 0007595584000001
    Figure 0007595584000001
  • Figure 0007595584000002
    Figure 0007595584000002
  • Figure 0007595584000003
    Figure 0007595584000003
Patent Text Reader

Abstract

The present disclosure provides a system, including a method and device for culturing, monitoring and / or analyzing organoid.In the exemplary method of organoid culturing, the method can include the step of placing a scaffold in a receptacle with an open side.A sealing member can be attached to the open side of the receptacle to generate a chamber.Organoid can be formed in the chamber using the scaffold.Fluid and / or at least one substance can be introduced into the chamber from the reservoir that covers the top, so as to contact with organoid.
Need to check novelty before this filing date? Find Prior Art

Description

[Background technology]

[0001] (CROSS REFERENCE TO RELATED APPLICATIONS) This application claims priority to U.S. Provisional Application No. 16 / 407,026, filed May 8, 2019, the contents of which are incorporated by reference herein in their entirety.

[0002] Organoids ("mini-organs") are different types of three-dimensional cell masses that are produced in vitro and have certain similarities to organs, such as exhibiting realistic histology of organ-specific tissues. Cell masses can be generated by seeding a small number of stem cells onto a substrate. The stem cells then proliferate, differentiate, and self-organize within the substrate, using the substrate as a scaffold. Using this approach, organoids have been generated so far that resemble tissues from the brain, heart, intestine, kidney, liver, and stomach, among others. These promising results suggest that organoid cultures have the potential to provide new insights into organ development and function, and to recapitulate disease models that enable drug screening in vitro. Organoids could revolutionize the way drugs are discovered and medicine is personalized.

[0003] There are several issues that limit researchers' ability to fully utilize organoids. First, as organoids increase in size, they may need to be fed both from the inside and the outside, posing a challenge. Second, each different type of organoid may require an optimized three-dimensional substrate scaffold structure, appropriate medium exchange (feeding) for that structure, and possibly even the ability to undergo mechanical resistance or controlled forces to allow proper growth and development of functioning organoids. Third, there is no container that is optimized to expose large organoids to different types of reagents and allow screening. Fourth, there is no container that is optimized to monitor large organoids in situ by imaging methods. Instead, organoids are often imaged after being physically fixed and sectioned. Thus, systems and methods are needed to improve organoid culture, such as by providing the ability to efficiently grow, monitor, and analyze large organoids. Summary of the Invention [Means for solving the problem]

[0004] The present disclosure provides a system, including a method and device, for culturing, monitoring, and / or analyzing organoid or other organized multicellular structures.In an exemplary method of organoid culturing, the method can include placing a scaffold in a receptacle having an open side.A sealing member can be attached to the open side of the receptacle to generate a chamber.An organoid can be formed in the chamber using the scaffold.A fluid and / or at least one substance can be introduced into the chamber from an overlying reservoir for contact with the organoid. The present invention provides, for example, the following: (Item 1) 1. A method of organoid culture, the method comprising: placing a scaffold within a receptacle having an open side; adhering a seal member to an open side of the receptacle to create a chamber; forming organoids in the chamber using the scaffold; A method comprising: (Item 2) 2. The method of claim 1, wherein bonding comprises bonding a prefabricated seal member to the receptacle. (Item 3) 2. The method of claim 1, wherein bonding includes forming the seal member by solidifying a seal material at least partially within the receptacle. (Item 4) 2. The method of claim 1, further comprising introducing a fluid and / or at least one substance into the chamber from an overlying reservoir integrally formed with the receptacle. (Item 5) 2. The method of claim 1, wherein positioning the scaffold comprises 3D printing the scaffold within the receptacle. (Item 6) 2. The method of claim 1, further comprising capturing an image of at least a portion of the organoid while the organoid is located within the chamber. (Item 7) 7. The method of claim 6, wherein capturing comprises capturing the image by light sheet microscopy. (Item 8) 1. A method of organoid culture, the method comprising: Positioning a scaffold on a wall of the receptacle; attaching a seal member to an open side of the receptacle opposite the wall to create a chamber; forming organoids in the chamber using the scaffold while the sealing member is located at the bottom of the chamber; A method comprising: (Item 9) 9. The method of claim 8, wherein positioning a scaffold comprises 3D printing the scaffold within the receptacle. (Item 10) 10. The method of claim 9, wherein 3D printing comprises incorporating stem cells into the scaffold. (Item 11) 9. The method of claim 8, wherein attaching the seal member includes adhering the seal member to the open side of the receptacle. (Item 12) creating an opening in a top wall of the chamber; inserting an end of an instrument through said opening and into said chamber; The method of claim 8, further comprising: (Item 13) Item 13. The method of item 12, wherein the instrument is selected from the group consisting of a needle, a light guide operably connected to a light source, an endoscope, an electrode, an ATR probe, a pneumatic / hydraulic source coupled to a balloon, and a magnet. (Item 14) 1. A method of organoid culture, the method comprising: Positioning a scaffold on a wall of the receptacle; attaching a seal member to the receptacle to create a chamber; forming organoids in the chamber using the scaffold; introducing a fluid and / or at least one substance from an overlying reservoir through the wall into the chamber for contact with the organoids; A method comprising: (Item 15) 15. The method of claim 14, wherein introducing comprises passing the fluid and / or at least one substance into the chamber via a channel extending through the overlying reservoir and a wall intermediate the chamber. (Item 16) The method of claim 14, wherein the introducing comprises passing nutrients through a top wall of the chamber to supply the organoids. (Item 17) 15. The method of claim 14, wherein introducing comprises passing one or more solidifying and / or clarifying agents through a top wall of the chamber. (Item 18) 15. The method of claim 14, wherein introducing comprises driving fluid from the reservoir into the chamber using gravity. (Item 19) Item 15. The method of item 14, wherein introducing comprises driving a fluid from an inlet to an outlet of the chamber, the inlet and the outlet each comprising a channel extending through a top wall of the chamber. (Item 20) forming a plurality of organoids in a corresponding plurality of chambers; applying a different treatment to each of the organoids; 15. The method of claim 14, further comprising: (Item 21) 21. The method of claim 20, wherein applying a different treatment comprises introducing a different test compound into each chamber of the plurality of chambers. (Item 22) 21. The method of claim 20, wherein applying the different treatments comprises modifying the genetic material of each organoid in its individual chamber by genome editing. (Item 23) The method of claim 20, wherein applying the different treatments comprises in vivo labeling of at least one genomic locus or using one or more DNA binding agents to modify the gene expression profile of each organoid in its individual chamber. (Item 24) 21. The method of claim 20, further comprising collecting data for each organoid of the plurality of organoids and testing the different treatments for an effect on the organoid. (Item 25) 25. The method of claim 24, wherein collecting data includes imaging each organoid in situ within its individual chamber. (Item 26) 25. The method of claim 24, wherein collecting data comprises chemically analyzing individual fluids associated with each organoid for an analyte. (Item 27) 25. The method of claim 24, wherein collecting data comprises removing each organoid from the chamber and collecting data from the organoid after removal from the chamber. (Item 28) 28. The method of claim 27, wherein collecting data comprises physically sectioning each organoid after removal from its chamber. (Item 29) Item 15. The method of item 14, wherein a first reservoir and a second reservoir overlie and are in separate fluid communication with the chamber, the method further comprising disposing a flexible membrane over the first reservoir and applying pressure to an upper side of the flexible membrane to drive fluid from the first reservoir through the chamber to the second reservoir. [Brief description of the drawings]

[0005] [Figure 1] FIG. 1 is a schematic side view of an exemplary vessel for forming, culturing, monitoring, and analyzing organoids, shown with the vessel holding organoids submerged in liquid culture medium and with the front and back walls of the vessel not visible. [Diagram 2]FIG. 2 is an exploded side view of the container of FIG. 1 taken while the container is empty. [Diagram 3] Figure 3 is a side view of the body of the container of Figure 2 taken alone and inverted relative to Figure 2 prior to implementation of a method of culturing, monitoring, and / or analyzing organoids within the container, as illustrated in Figures 4-10. [Figure 4] 4 and 5 are side views of the vessel body of FIG. 3 taken during and after generation of a scaffold within the vessel receptacle by 3D printing or pipetting, respectively. [Diagram 5] 4 and 5 are side views of the vessel body of FIG. 3 taken during and after generation of a scaffold within the vessel receptacle by 3D printing or pipetting, respectively. [Figure 6] FIG. 6 is a side view of the container body of FIG. 5 taken after a prefabricated seal member has been bonded to the container body to seal the open side of the receptacle and produce a chamber containing the scaffold. [Figure 7] FIG. 7 is a side view of the container body and sealing member of FIG. 6 taken after the container body has been inverted into an organoid culture orientation, at least one liquid medium has been introduced into the scaffold-containing chamber and into an overlying reservoir in fluid communication with the chamber, and the container lid has been placed over the open top of the reservoir. [Figure 8] FIG. 8 is a side view of the vessel of FIG. 7 obtained after proliferation and differentiation of stem cells within the scaffold to generate organoids. [Figure 9] FIG. 9 is a side view of the vessel of FIG. 8 obtained after reconstitution / replacement of the scaffold with developing organoids. [Figure 10] FIG. 10 is a side view of the vessel of FIG. 9 taken as the organoids were imaged by light sheet microscopy. [Figure 11] 11-13 are side views of the container body and scaffold of FIG. 5 illustrating an alternative approach to sealing the open side of a receptacle in the container body and producing a chamber by forming a seal member in situ within the receptacle. [Figure 12]11-13 are side views of the container body and scaffold of FIG. 5 illustrating an alternative approach to sealing the open side of a receptacle in the container body and producing a chamber by forming a seal member in situ within the receptacle. [Figure 13] 11-13 are side views of the container body and scaffold of FIG. 5 illustrating an alternative approach to sealing the open side of a receptacle in the container body and producing a chamber by forming a seal member in situ within the receptacle. [Figure 14] Figure 14 is a side view of the container body, sealing member, and scaffold of Figure 13 taken after, in the presence of an imaging objective, the container body has been inverted into an organoid culture orientation, at least one liquid medium has been introduced into the chamber containing the scaffold and into an overlying reservoir in fluid communication with the chamber, and a container lid has been placed over the open top of the reservoir. [Figure 15] Figure 15 is a side view of the container body and scaffold of Figure 12 illustrating a modified approach, relative to Figure 13, to sealing the open side of the receptacle of the container body and producing a chamber by forming a seal member in situ within the receptacle. [Figure 16] FIG. 16 is a schematic side view of an exemplary container strip for forming, culturing, monitoring, and / or analyzing arrays of organoids, where the container strip has a set of containers directly connected to each other. [Figure 17] FIG. 17 is a schematic side view of the container strip of FIG. 16 obtained during culture of organoids and illustrating an exemplary pump configuration for transferring liquid medium between reservoirs within each container of the container strip. [Figure 17A] 17A and 17B are schematic side views of the vessel strip of FIG. 16 obtained during culture of organoids, illustrating how tilting the vessel strip in counter-rotating directions can drive flow in separate, opposing directions within each chamber. [Figure 17B]17A and 17B are schematic side views of the vessel strip of FIG. 16 obtained during culture of organoids, illustrating how tilting the vessel strip in counter-rotating directions can drive flow in separate, opposing directions within each chamber. [Figure 18] FIG. 18 is a schematic side view of another embodiment of an exemplary container strip having an array of containers obtained during culture of organoids and illustrating an exemplary pump configuration for transferring liquid medium between reservoirs of different containers of the container strip. [Figure 19] 19 is a diagram of an exemplary embodiment of a container body for the container of FIG. 2. [Figure 20] FIG. 20 is a front view of the container body of FIG. [Figure 21] FIG. 21 is a view of the container body of FIG. 19 taken with the container body inverted and the prefabricated seal member disassembled from its receptacle in the container body. [Figure 22] 22 is a bottom view of the container body of FIG. 19 taken generally along line 22-22 of FIG. 20. [Figure 23] 23 is a top view of the container body of FIG. 19 taken generally along line 23-23 of FIG. 20. [Figure 24] 24 is a cross-sectional view of the container body of FIG. 19 taken generally along line 24-24 of FIG. [Diagram 25] 25 is another cross-sectional view of the container body of FIG. 19 taken generally along line 25-25 of FIG. 23. [Figure 26] 26 is a partial cross-sectional view of another embodiment of a container body taken generally as in FIG. 25, except that only the lower portion of the container body differs from that of FIG. [Figure 27] FIG. 27 is a partial cross-sectional view of the vessel body of FIG. 26 taken after porous tubes have been formed between the channels of the vessel body by 3D printing. [Figure 28] FIG. 28 is a cross-sectional view of yet another embodiment of a container body taken as in FIG. 25, with the container body including an electromagnet operatively associated with a receptacle in the container body. [Figure 29] FIG. 29 is a partial view of the container body of FIG. 28 adhered to a sealing member to create a chamber with the scaffold connected to the ceiling of the chamber, the cells located on the floor of the chamber, the cells being ferromagnetic, and the electromagnet turned off. [Diagram 30] FIG. 30 is another partial view of the container body, sealing member, scaffold, and cells of FIG. 29 taken with the electromagnet turned on such that the ferromagnetically labeled cells are being pulled into the scaffold by magnetic force. [Diagram 31] FIG. 31 is a top view of an exemplary rack for holding a linearly arranged set of containers as strips during scaffold generation and organoid formation and culture, each container comprising a container body corresponding to the embodiment of FIG. [Diagram 32] 32 is a top view of the rack of FIG. 31 assembled with a set of container bodies corresponding to the embodiment of FIG. 19 to produce strips. [Diagram 33] FIG. 33 is a side view of the strip of FIG. [Diagram 34] 34 is a top view of another exemplary rack for holding a two-dimensional array of container bodies corresponding to the embodiment of FIG. 19 and for producing strips. [Diagram 35] Figure 35 is a cross-sectional view of yet another embodiment of a container body for the container of Figures 1 and 2, taken generally as in Figure 25 (with respect to related embodiments), with the open bottom end of the container body sealed with a sealing member to form a chamber, the container body defining an access tube closed at its bottom end by a breakable barrier, and a magnet inserted into the access tube to position the working end of the magnet adjacent to (and above) the breakable barrier. [Diagram 36] Figure 36 is a cross-sectional view of the container body and sealing member of Figure 35 taken with an organoid present in the chamber and the magnet replaced by a needle having a tip that has pierced the breakable barrier and entered the organoid. [Figure 37]Figure 37 is a cross-sectional view of the container body and sealing member of Figure 35 taken with an organoid present in the chamber and the magnet replaced by a sensor / electrode having a sensing / stimulation end region that has pierced the breakable barrier and entered the organoid. [Figure 38] 38-40 are partial cross-sectional views of the container body of FIG. 35 taken around the breachable barrier before, during, and after the tip of a breaching instrument has passed from the access tube through the barrier and into the chamber. [Figure 39] 38-40 are partial cross-sectional views of the container body of FIG. 35 taken around the breachable barrier before, during, and after the tip of a breaching instrument has passed from the access tube through the barrier and into the chamber. [Diagram 40] 38-40 are partial cross-sectional views of the container body of FIG. 35 taken around the breachable barrier before, during, and after the tip of a breaching instrument has passed from the access tube through the barrier and into the chamber. [Diagram 41] FIG. 41 is a cross-sectional view of the container body and sealing member of FIG. 35 taken generally as in FIG. 24 (with respect to the related embodiment) with a breakthrough tool positioned within the three access tubes and only one of the breakthrough tools extending into the chamber below the access tubes so that the three access tubes are visible. [Diagram 42] 42-44 are partial cross-sectional views of a modified embodiment of the container body of FIG. 35 in which the breachable barrier is configured to tear at the frangible web, with views taken around the breachable barrier before, during, and after the tip of the breaching tool has passed from the access tube through the breachable barrier. [Diagram 43] 42-44 are partial cross-sectional views of a modified embodiment of the container body of FIG. 35 in which the breachable barrier is configured to tear at the frangible web, with views taken around the breachable barrier before, during, and after the tip of the breaching tool has passed from the access tube through the breachable barrier. [Diagram 44]42-44 are partial cross-sectional views of a modified embodiment of the container body of FIG. 35 in which the breachable barrier is configured to tear at the frangible web, with views taken around the breachable barrier before, during, and after the tip of the breaching tool has passed from the access tube through the breachable barrier. [Diagram 45] Figure 45 is a cross-sectional view of the container body and sealing member of Figure 35 taken with an organoid present in the chamber and the magnet replaced by an attenuated total reflection (ATR) optical fiber probe having a tip that has pierced the breakable barrier and entered the organoid. [Diagram 46] Figure 46 is a cross-sectional view of the container body and sealing member of Figure 35 taken with an organoid present in the chamber and the magnet replaced by an imaging optical fiber probe having a front lens that has passed through a breakable barrier and entered the organoid. [Figure 47] FIG. 47 is a cross-sectional view of the container body and sealing member of FIG. 35 taken with an organoid present in the chamber and the magnet replaced by an illumination probe having a distal end that has entered the organoid. [Figure 48] FIG. 48 is a cross-sectional view of the container body and sealing member of FIG. 35 taken with an organoid present in the chamber and the magnet replaced by a pneumatic device having an expandable balloon positioned inside the organoid to generate internal mechanical strain. [Figure 49] Figure 49 is a cross-sectional view of the container body and sealing member of Figure 35, obtained as in Figure 24 (with respect to a related embodiment), with organoids present in the chamber and the magnet replaced by a pair of pneumatic devices having expandable balloons positioned outside the organoids to generate external mechanical strain. [Figure 50] Figures 50 and 51 are views of the container body and sealing member of Figure 35, generally taken as in Figures 25 and 24, respectively (for similar embodiments), with a pair of magnets extending into the chamber via corresponding access tubes and loading a pre-fabricated scaffold structure or biochip onto the magnets via magnetic forces. [Figure 51] Figures 50 and 51 are views of the container body and sealing member of Figure 35, generally taken as in Figures 25 and 24, respectively (for similar embodiments), with a pair of magnets extending into the chamber via corresponding access tubes and loading a pre-fabricated scaffold structure or biochip onto the magnets via magnetic forces. [Figure 52] Figures 52 and 53 are cross-sectional views of the container body and sealing member of Figure 35 taken with a cap mounted on top of the container body to hermetically seal it and provide a flexible member that is deformed by external pressure applied alternately across a pair of reservoirs to drive liquid through the chambers in alternately opposite directions. [Figure 53] Figures 52 and 53 are cross-sectional views of the container body and sealing member of Figure 35 taken with a cap mounted on top of the container body to hermetically seal it and provide a flexible member that is deformed by external pressure applied alternately across a pair of reservoirs to drive liquid through the chambers in alternately opposite directions. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

[0006] The present disclosure provides a system, including, inter alia, methods and devices for culturing, monitoring, and / or analyzing organoids or other organized multicellular structures, such as developing or fully developed multicellular organisms, tissue biopsies, and / or primary patient material.In an exemplary method of organoid culturing, the method can include placing a scaffold in a receptacle having an open side.A sealing member can be attached to the open side of the receptacle to generate a chamber.An organoid can be formed in the chamber using the scaffold.A fluid and / or at least one substance can be introduced into the chamber from an overlying reservoir for contact with the organoid.

[0007] The present disclosure describes, among other things, containers for the formation, culture, monitoring, and / or analysis of organoids or other organized multicellular structures, such as developing or fully developed multicellular organisms, tissue biopsies, and / or primary patient material. The containers may be consumable (i.e., disposable after a single use) and / or may have a standard shape. The containers may include a container body defining a receptacle having an open side. A sealing member may be attached (e.g., glued) to the container body to form a chamber from the receptacle. The sealing member may be, among other things, preformed or formed in the receptacle.

[0008] A three-dimensional (3D) structure (i.e., at least one substrate, which may be a scaffold) may be placed in the receptacle before its open side is sealed. The 3D structure may be formed in the receptacle by a 3D printer. The 3D printer may dispense one or more solidifiable bio-inks, which may be mixed with the cells before or as the ink is deposited to generate the 3D structure. Alternatively, the cells may be introduced into the receptacle or chamber separately from the 3D structure. In other embodiments, the 3D structure may be formed at least partially or completely outside the receptacle and then placed therein.

[0009] Suitable cells that may be introduced into the matrix scaffold as generated or after generation may include undifferentiated stem cells, stem cells that have already differentiated and will continue to differentiate, cell aggregates, miniature organoids, and / or the like.

[0010] The 3D printer may also be utilized to apply adhesive and / or sealing fluid to the container body to allow sealing of the open side of the receptacle with a transparent sealing member at the end of the printing process. Exemplary printing techniques that may be suitable for dispensing substrate components include droplet-based bioprinting using bioinks or laser-based bioprinting (e.g., laser-based direct writing to print cells, enzymes, etc., by laser-induced forward transfer (LIFT) using a pulsed laser).

[0011] The scaffold and / or other substrate may be provided by one or more hydrogels, each of which may include one or more thermoplastic structural components, such as matrigel, alginate, nanofibrous cellulose, collagen, fibrin, and / or polyethylene glycol, among others, that cooperatively form the substrate in a temperature-dependent manner.

[0012] In some embodiments, two or more different hydrogels / substrates may be disposed within the receptacle. The hydrogels / substrates may differ in any suitable parameter, such as melting temperature, resistance to enzymatic degradation, solubility, cell-attracting and / or cell-repelling properties, and / or the like.

[0013] Each hydrogel / matrix may include any suitable component. Exemplary components include one or more polysaccharides (e.g., glycosaminoglycans (GAGs such as chondroitin sulfate, dermatan sulfate, heparin, heparan sulfate, hyaluronic acid, keratan sulfate, etc.), proteoglycans (e.g., GAGs linked to a core protein (such as through its serine) to form aggrecan, agrin, brevican, collagen XVIII, leprecan, neurocan, perlecan, small leucine-rich proteoglycan, versican, or the like), fibrous proteins (e.g., collagen, elastin, fibronectin, laminin, etc.), and / or the like. Protease recognition sites (e.g., for scaffold metalloproteinases (MMPs)) may be incorporated into the hydrogel / matrix to allow for degradation / remodeling by cells. The frequency of such sites, along with the sequence of each site, may be selected to allow a suitable amount of degradation / remodeling.

[0014] One or more growth factors may be included in the matrix as it is formed or may be introduced into the liquid medium after formation. Exemplary growth factors that may be suitable include angiopoietin, bone morphogenetic protein (BMP), ciliary neurotrophic factor, colony stimulating factors, ephrins, epidermal growth factor, erythropoietin, fibroblast growth factor, glial derived neurotrophic factor, hepatocyte growth factor, insulin, insulin-like growth factor, interleukins, leukemia inhibitory factor, keratinocyte growth factor, neuregulin, neurotrophins, platelet-derived growth factor, transforming growth factor, tumor necrosis factor (alpha), vascular endothelial growth factor, and / or the like.

[0015] Any suitable cells may be initially populated into the scaffold. These cells may include stem cells (e.g., pluripotent stem cells), support cells, and / or the like. The cells may be deposited into the scaffold by any suitable technique, including bio-ink droplet printing, microcontact printing, photolithography, dip-pen nanolithography, and / or pipetting, among others.

[0016] The container may provide multiple reservoirs, which may be formed in a shared wall between the reservoirs and the chambers, and are in fluid communication with the chambers through channels. This configuration may be described as a standard supply interface. In some embodiments, 3D printing provides the connection of the standard supply interface inside the container to any suitable printed structure, allowing the growth of different types of organoids.

[0017] Printed 3D structures can provide a temporary scaffold for appropriate types of cells as they develop into organoids. Cells can self-organize and produce their own extracellular matrix, which can replace part or all of the scaffold. The same can be true for internal replenishment, i.e., the container can provide a general interface that can be modified by 3D printing at will, and cells can organize and use this modified interface to the best of their ability.

[0018] The scaffold (with or without cells) may be placed in the receptacle of the container body, and a chamber may be formed from the receptacle while the container is upside down. Once these processes are completed, the container may be turned right side up (in its organoid culture orientation), and at least one reservoir that covers the top of the chamber may be filled with a replenishment liquid. If there are no cells inside the scaffold yet, suitable cells may be placed in the replenishment liquid and introduced into the scaffold together with the replenishment liquid from the overlying reservoir (or cells may be introduced through an access tube (see, for example, Example 7)).

[0019] Forming organoid may require initial incubation time before specific feeding protocol can be started.Federation protocol can involve loading suitable medium into reservoir according to a predetermined schedule and / or based on the development stage or condition of organoid, and then removing medium from reservoir.Federation protocol can depend on the shape of scaffold and the type of organoid to be formed.

[0020] The container may be structured to allow organoid monitoring through a bottom window of the chamber, which may be provided by a sealing member. In some embodiments, the organoids may be monitored while remaining inside the incubator. Thus, the incubator may include an imaging system for organoid monitoring.

[0021] The container may enable light sheet 3D imaging. The chamber of the container may have two, three or more optical windows, and light may propagate into and / or out of the chamber through each window. For example, the container may have a bottom window and one or more side windows, each of which may be planar. In some embodiments, the container may have a pair of side windows arranged opposite each other.

[0022] A plurality of container bodies (containers) may be organized as a strip. The strip may be generated by pre-attaching the container bodies to each other in a linear or two-dimensional array during manufacturing (e.g., by gluing or forming the container bodies integrally with each other, such as by injection molding). Alternatively, the strip may be generated during manufacturing or by a user by assembling the individual container bodies with a suitable strip holder. In some embodiments, the strip holder may be configured to hold only one strip or two strips, allowing room for an imaging objective. The strip of container bodies may be loaded into a 3D printer to allow the printer to print a scaffold and / or add a seal member to each of the container bodies.

[0023] The present disclosure allows the generation of large functional organoids by feeding different media to organoids inside and outside. Large organoids can be, among others, larger than about 0.1, 0.2, 0.5, 1, or 2 millimeters in average or maximum diameter. Working with large organoids is still difficult, and researchers face two major limitations. First, each type of organoid requires different culture conditions, such as specific hydrogels, substrates as base materials, or even mechanical properties such as shear forces due to medium flow. Second, microscopic examination of large organoids is very difficult. The state-of-the-art method is still to slice organoid material, stain, and obtain images of fixed samples using confocal scanning microscopes or even slide readers.

[0024] The present disclosure provides systems and methods to facilitate overcoming one or both obstacles. By using a combination of 3D printing (scaffolds and / or cells) along with medium exchange by gravity flow, users may generate unique 3D environments optimized for each type of organoid. A wide range of different organoid types may be grown. Replenishment and waste removal may be addressed by fluid communication between the chamber of the container and the overlying reservoir. Integrating optical windows into each container, at least one for the entrance of excitation light and another for the exit of emission light, allows for monitoring the live cells of the organoid by light sheet microscopy. Alternatively or in addition, the organoid may be imaged by classical wide-field microscopy through one or more of the windows. Thus, the containers disclosed herein may allow for the performance of live cell microscopy of developing and / or developed organoids. High content and / or high throughput microscopy may be performed on the organoids.

[0025] Further aspects of the present disclosure are described in the following sections: (I) Vessels for organoid formation, culture, monitoring, and / or analysis; (II) Methods for organoid formation, culture, monitoring, and / or analysis; and (III) Examples.

[0026] I. Vessels for organoid formation, culture, monitoring, and / or analysis This section describes an exemplary container 50 for the formation, culture, monitoring, and / or analysis of organoids 52 (or other organized multicellular structures). See Figures 1 and 2. The container 50 is shown here diagrammatically with no visible front and back walls to distinguish between the top and bottom sides of the container, which are closed (Figure 1) or open (Figure 2).

[0027] 1 shows a vessel 50 containing organoids 52 within a chamber 54, where the organoids are submerged in a medium 56 (e.g., a liquid or semi-solid culture medium for encouraging organoid growth and development). The organoids 52 may be attached to an upper region of the chamber 54, such as its top wall 58. (The top wall is interchangeably referred to as the ceiling.) The side walls 60 and bottom wall 62 of the chamber may provide a barrier to allow fluids to pass therethrough, thereby making all of the chamber below the top wall 58 liquid-tight.

[0028] The container 50 defines a number of compartments 63 located across the chamber 54. Each compartment 63 may share a wall with the chamber 54 and may or may not be in fluid communication with the chamber initially. An exemplary compartment includes a reservoir and an access tube (see Example 7). Here, the container 50 includes (at least) two reservoirs 64a, 64b for holding separate liquid media 66a, 66b across the chamber 54. Each reservoir 64a, 64b may be in fluid communication with the chamber 54 independently of each other reservoir via a corresponding dedicated channel 68a, 68b. Each channel 68a, 68b may extend through the top wall 58 from one of the reservoirs 64a, 64b to the chamber 54 and may be flush with the top and bottom sides of the top wall 58 or may protrude from the top and / or bottom sides of the top wall 58 as a lumen of an annular protrusion (see, for example, Example 4). In other embodiments, container 50 may have at least, or exactly, three, four, five, six, or more overlying reservoirs, each of which may be in fluid communication with chamber 54 through top wall 58 and / or independently of each other reservoir (see, e.g., Example 3).

[0029] The two or more reservoirs of the container 50 may hold any suitable substance to be provided to the chamber 54. Exemplary substances include nutrients, agents, and reagents, among others. Suitable nutrients include any substance to promote cell health and proliferation, and thus the growth and development of the organoids 52, inside the chamber 54. Exemplary nutrients may include sugars (such as glucose), amino acids, proteins, nucleotides, vitamins, minerals, fatty acids, and the like. Agents include any molecule (such as inducers or inhibitors) that activate, regulate, or inactivate a process or action (such as differentiation, protein synthesis, migration, and the like). Exemplary agents include anti-cancer compounds, growth factors, differentiation factors, oligonucleotides, mRNA, or the like. Reagents include any compound that facilitates the analysis of the organoids. Exemplary reagents include labels, solidifying agents, and clarifying agents, among others. Labels may include dyes (e.g., visible stains and / or photoluminescent dyes). A photoluminescent dye is any material that emits light in response to illumination by excitation light.

[0030] Each reservoir 64a, 64b may have a side wall 70 for containing fluid laterally. At least one side wall may be shared between at least one pair of adjacent reservoirs, as depicted in Figure 1. In other embodiments, at least one pair of reservoirs of the same or different containers may be in fluid communication with one another laterally, independent of the chamber 54, such as via a channel formed in a wall 70 shared between the reservoirs (see, e.g., Example 2).

[0031] Each reservoir 64a, 64b may have an open top 72 to facilitate introduction and removal of fluids with a fluid transfer device (e.g., a pipette or other pump). The container 50 may include a single removable lid 74 that fits over the container and covers the open top 72 of each reservoir 64a, 64b during incubation in the incubator. Alternatively, the container may include two or more lids that are independently removable from one another and collectively cover all of the reservoirs. Each lid 74 may have a flange 76 that vertically overlaps the top of each reservoir and is optionally configured to limit lateral movement of the lid when covering the reservoir without creating a tight fit. In some embodiments, the lid may be a cap that forms a fluid-tight seal over the top of one or more reservoirs (see, e.g., Example 8).

[0032] FIG. 2 shows an exploded view of the container 50 of FIG. 1, with the container empty. The container 50 may include a lid 74, a container body 78, and a sealing member 80. The container body 78 may define the reservoirs 64a, 64b, and a receptacle 82 below the reservoirs. The receptacle 82 provides the top wall 58 and the side walls 60 of the chamber 54. However, the receptacle 82 may have an open bottom side 84 that may be sealed with a flat sealing member 80 to create the chamber 54 after a scaffold 86 for supporting organoid formation is placed within the receptacle 82 (see FIG. 1 and Section II). The sealing member may be adhered to the bottom end of the receptacle 82 (and / or the container body 78) to create the chamber 54. In other embodiments, the sealing member may be formed in situ to seal the bottom side 84 of the receptacle 82 (see Section II).

[0033] The vessel 50 may have one or more optical windows to facilitate imaging (see FIG. 1). Each optical window may be used to transmit light into the chamber, to illuminate at least a portion of the chamber 54, or to receive light from the chamber, such as for imaging.

[0034] In the exemplary embodiment, container 50 has a bottom window 88 provided by seal member 80 and one or more side windows 90 provided by container body 78. Each optical window may be transparent and / or planar. Bottom window 88 may intersect (e.g., orthogonal to) each side window 90, which may be formed by opposing side walls 60 of chamber 54. (The term "light" as used herein means optical radiation, including ultraviolet radiation, visible radiation (i.e., visible light), and / or infrared radiation.)

[0035] The components of the container 50 may be formed from any suitable material by any suitable procedure. In an exemplary embodiment, the container body 78 may be formed from a polymer, such as a transparent polymer. The container body may not have any removable / movable parts and / or may be formed as a single piece, such as by injection molding, such that all of the structures (e.g., compartments) of the container body are integrally formed with one another. Thus, the receptacle 82 (and / or chamber 54) and reservoirs 64a, 64b may have a fixed position relative to one another and / or may be non-removably / rigidly attached to one another. The seal member 80 may be formed from glass or a polymer, among others, and may be preformed or formed in situ at least partially or completely inside the receptacle 82.

[0036] The chamber 54 (and / or receptacle 82) and each reservoir 64a, 64b may have any suitable size. The chamber 54 may have a volume of at least about 0.1, 0.2, 0.3, 0.4, 0.5, 0.7, or 1 mL. The chamber may be sized to contain organoids of any suitable size (e.g., maximum size), such as organoids having a diameter of at least about 0.2, 0.5, 1, 2, 3, 4, or 5 mm, among others. In an exemplary embodiment, the reservoirs overlying each of the containers are at least as large as the volume of the chamber 54 (and / or receptacle 82), such as at least about 0.5, 1, 2, 4, or 6 mL, among others, or about 2, 5, or 10 times larger.

[0037] The container 50 and / or any of its compartments may have any suitable geometric shape. For example, the receptacle 82, the chamber 54, and / or each of the reservoirs (e.g., reservoirs 64a, 64b) may each, independently, have a polygonal (e.g., rectangular), elliptical (e.g., circular), oval, rosette, or other shape in cross section (e.g., in a horizontal plane). Thus, the receptacle 82, the chamber 54, and / or each of the reservoirs, independently, may be, among others, cylindrical, frustoconical, rectangular prism, tapered prism, or combinations thereof.

[0038] Further aspects of container 50 that may be suitable for organoid formation, culture, monitoring, and / or analysis are described below.

[0039] II. Methods of organoid formation, culture, monitoring, and / or analysis This section describes methods of forming, culturing, monitoring, and / or analyzing organoids (or other organized multicellular structures) in the containers of the present disclosure. See Figures 3-15. The method steps described in this section may be performed in any suitable order or combination, using any of the containers, container features, and / or procedures described elsewhere herein.

[0040] 3-10 illustrate exemplary configurations of containers 50, organoids 52, and media 56, 66a, 66b produced by the implementation of the organoid culture and analysis method. At least one container body 78 of at least one container 50 may be selected for use. In some embodiments, a linear or two-dimensional array of container bodies 78 may be selected (see, e.g., Examples 1 and 6), or an array may be generated after at least a subset of the steps described below are performed.

[0041] 3 shows the container body 78 selected and installed in an inverted orientation with the receptacle 82 open at the top. In other words, the top wall 58 is positioned below the open bottom side 84. This orientation utilizes gravity to encourage fluid delivery onto the top wall 58 while the side walls 60 prevent lateral fluid flow out of the receptacle 82.

[0042] A scaffold 86 to be used for organoid formation may be placed inside the receptacle 82. The scaffold may be included in a hydrogel 92 that is at least partially generated in situ, as shown in Figures 4 and 5. For example, the scaffold 86 of the hydrogel 92 may be printed in three dimensions on the top wall 58 by a 3D printer 94. The 3D printer 94 may utilize any suitable technique to deliver the components of the scaffold. In some embodiments, the 3D printer may utilize inkjet technology to deliver droplets of fluid (such as droplets 95) that may contain scaffold structural components, cells 96, tubes, caged agents, growth factors, etc. Alternatively or in addition, the 3D printer 94 may utilize laser-induced forward transfer to deliver the components (e.g., cells 96), among others. In other embodiments, at least a portion of the scaffold 86 may be generated separately from the container body 78 and placed in the receptacle 82 (e.g., attached to the top wall 58).

[0043] The hydrogel 92 may or may not be a thermoreversible gel. The hydrogel may have a gel point (gelling temperature) above the culture temperature for the organoids such that the hydrogel scaffold forms through cooling as the scaffold is printed. Alternatively or additionally, polymerization to form the hydrogel may be photoinduced using optical radiation such as ultraviolet or visible light, among others.

[0044] The scaffold 86 (and / or hydrogel 92) may overlap horizontally the bottom ends of one or more channels 68a, 68b. For example, in the depicted embodiment, a through axis (e.g., a vertical axis) defined by channel 68b intersects the hydrogel 92 and extends through the scaffold 86. In other embodiments, the scaffold 86 (and / or hydrogel 92) may overlap multiple channels 68a, 68b.

[0045] One or more channels 68a, 68b may be extended by 3D printing during the generation of the scaffold 86 within the hydrogel 92 to facilitate the supply of nutrients and / or agents to the hydrogel 92 and the cells 96 therein during organoid formation and culture. The resulting channel extensions may be one or more laterally permeable tubes embedded in the hydrogel 92, which may be branched to form a channel network inside the hydrogel. The channel network and / or the laterally permeable tubes embedded in the hydrogel 92 may extend between at least a pair of channels 68a, 68b of the container body 78. Agents (such as differentiation factors) may be supplied through the channel network to establish a concentration gradient inside the hydrogel for more controlled stem cell differentiation and organoid formation. The tubes may be generated by photoinduced or thermal polymerization, among others. Preformed tubes may also or alternatively be incorporated into the hydrogel or scaffold for additional promotion of liquid flow within the hydrogel / scaffold.

[0046] The open side of the receptacle 82 may be hermetically sealed to produce a chamber 54 containing the hydrogel 92 and scaffold 86 therein. A seal member 80 may be adhered to an end of the receptacle 82, as shown in FIG. 6. Alternatively, the seal member 80 may be generated in situ by polymerization and / or solidification of a sealing fluid, at least partially inside the receptacle 82, as described below. The receptacle 82 may be sealed before or after the cells 96 are placed into the receptacle and / or before or after the medium 56 is placed into the receptacle 82 (and / or chamber 54) around the hydrogel 92.

[0047] The medium 56, 66a, 66b may be disposed in the chamber 54 and each reservoir 64a, 64b of the container 50. See FIG. 7. The same medium may be introduced into each chamber and reservoir, or different medium may be introduced, which may generate a concentration gradient of one or more nutrients and / or agents. As explained above, the medium 56 may be introduced first through the open side of the receptacle 82 before the receptacle is sealed to generate the chamber 54. Before the chamber 54 is generated, the end of each channel may be coated with a hydrogel 92 (or a different hydrogel) to prevent leakage of the medium 56 from the receptacle 82 through one or more channels 68a, 68b. The different hydrogel may be configured to melt below an incubation temperature (such as 37° C.) for organoid formation and culture. Alternatively, the medium 56 may be introduced into the chamber 54 (after the chamber is formed) from at least one reservoir 64a, 64b via at least one channel 68a, 68b.

[0048] Gravity may drive fluid from one of the reservoirs into chamber 54 and / or between reservoirs through the chambers if the fluid levels in the reservoirs are different. For example, in FIG. 7, the top of medium 66a in reservoir 64a is higher than the top of medium 66b in reservoir 64b. Thus, gravity drives the flow of medium 66a into chamber 54 through channel 68a (which serves as an inlet) and out of chamber 54 through channel 68b (which serves as an outlet). Over time, the levels of medium 66a, 66b will tend to equalize. Thus, fluid may be added to and / or removed from one or more of the reservoirs, or the vertical of container 50 may be periodically changed (see, for example, Example 2) to drive further fluid flow in the same or opposite direction.

[0049] 8 and 9 show a container 50 containing organoids 52. The organoids are formed by proliferation and differentiation of cells 96 within a hydrogel 92. In FIG. 9, the size and shape of the organoids 52 change relative to FIG. 8 as the scaffold 86 is remodeled by the cells of the organoids. In other embodiments, the final size and shape of the organoids 52 may be substantially dictated by the size and shape of the scaffold 86 as it is formed.

[0050] FIG. 10 shows an exemplary imaging system 100 for capturing an image 102 of an organoid 52 by light sheet microscopy. The imaging system may include an illumination assembly 104, including a light source 106 for generating light for a light sheet 108. The light sheet may be oriented horizontally and propagate through the organoid 52 from one of the side windows 90, as depicted in FIG. 10. Alternatively, the light sheet 108 may be oriented vertically and propagate through the organoid vertically from the bottom window 88. Light may be collected from the organoid 52 using an objective lens 110 for capture by an image sensor 112. The light propagating through the bottom window 88 may be collected as in the depicted embodiment, or the light may be collected from one of the side windows 90. The light sheet 108 may be moved by a corresponding movement of the illumination assembly 104 (or the container 50) to allow the capture of a stack of images, thereby providing three-dimensional image data for the organoid. When the organoids 52 no longer need to be viable, they may be fixed and cleared prior to imaging by supplying fixation and clearing reagents from one or more of the reservoirs 64a, 64b through the upper wall 58 of the chamber 54.

[0051] 11-13 illustrate an alternative in situ approach to sealing the open side 84 of the receptacle 82 and producing the chamber 54. FIG. 11 shows the container body 78 inverted after formation of the hydrogel 92 including the scaffold 86. Filler hydrogel 113 has also been dispensed into the open receptacle 82 via the open side 84, which may prevent leakage from the receptacle 82 through the channel 68a. The filler hydrogel may be configured to melt or dissolve once organoid culture begins. FIG. 12 shows the 3D printer 94 dispensing the sealing liquid 114 into the receptacle 82. FIG. 13 shows the sealing liquid 114 solidifying and hermetically sealing the open side of the receptacle 82, producing the chamber 54.

[0052] The sealing liquid may be configured to solidify to produce, among other things, a thermoplastic or thermosetting polymer. Exemplary thermoplastic polymers include thermoplastic elastomers or waxes, preferably having a melting point below 100° C. Lower melting points are desirable, but may be at least about 50° C. The thermoplastic polymer may be dispensed in liquid form onto the surface of the filler hydrogel 113 at a temperature above the melting temperature of the polymer to form the sealing layer 116, which hardens as the layer cools to produce the seal member 80.

[0053] In other examples, the layer may be allowed to solidify to produce a thermoset polymer.

[0054] 13 illustrates an example in which the sealing layer 116 is solidified into a thermosetting polymer by irradiation with optical radiation (e.g., ultraviolet light) from the illumination assembly 104. The illumination assembly preferentially irradiates the sealing layer 116 with ultraviolet light, thereby forming a light sheet 108 that minimizes photodamage to the scaffold 86 and / or cells 96 already present in the receptacle 82.

[0055] 14 shows the container body 78 inverted into its organoid culture orientation with the sealing layer 116 solidified to form a seal member 80 and medium 56, 66a, 66b within the chamber 54 and reservoirs 64a, 64b. The objective lens 110 of the imaging system collects light from the chamber 54 to form an image. The medium 56 and the sealing layer 116 may have substantially the same refractive index to improve image quality.

[0056] 15 illustrates a modified in situ approach for sealing the open side of the receptacle 82 of the container body 78 (compared to FIG. 13). A radiation blocking layer 118 may be formed on the surface of the filler hydrogel 113 before a layer 116 of heat-curable sealing liquid is added to the receptacle 82. The layer 116 may be irradiated with optical radiation from a light source 120 positioned above the container body 78 to induce solidification of the layer 116 and form the seal member 80. The radiation blocking layer 118 shields the hydrogel 92 from photodamage. EXAMPLES

[0057] III. Examples This section describes further embodiments of the system and method for organoid formation, culture, monitoring and / or analysis. These embodiments are intended for illustrative purposes only and should not limit the overall scope of the present disclosure.

[0058] Example 1: Strips for organoid culture This example describes an exemplary strip 130 for forming, culturing, monitoring, and / or analyzing arrays of organoids. See FIG.

[0059] The strip 130 may include an array of interconnected container bodies 78. The container bodies may be integrally formed with one another or formed separately and then connected to one another after formation (and / or after the receptacles 82 are sealed to form the chambers 54) (see also FIG. 1). Separately formed container bodies 78 may be connected to one another by adhesive, interference fit, fasteners, or holders, among others (see, e.g., Example 6). The container bodies may be connected to one another to create a linear or at least two-dimensional array of receptacles 82.

[0060] Example 2: Fluid transfer between container and reservoir This example describes an exemplary configuration for transferring fluid between reservoirs 64a, 64b of the same or different containers 50. See Figures 17, 17A, 17B, and 18.

[0061] FIG. 17 shows a strip 130 during the culture of organoids 52 in chambers 54. Each container 50 has a separate flow cycle, indicated by arrows 132, 134. The flow 132 through each chamber 54 between channels 68b and 68a is driven by gravity as a result of the difference in the levels of medium 66a, 66b in the respective reservoirs 64a, 64b. The refill flow 134 from reservoir 64a to reservoir 64b is driven by a pump 136. The flow rate of pump 136 can be adjusted to keep the respective levels of medium 66a, 66b substantially constant, so that fluid passes through chambers 54 at a substantially constant rate. This flow can apply pressure to the organoids 52, encouraging their growth and development. In other examples, the flow rate of pump 136 can be varied to apply different pressures to the organoids 52.

[0062] In other embodiments, the pump 136 can be eliminated, as shown for the vessel strip 130 in Figures 17A and 17B. The strip 130 may be rocked to tilt the holder from vertical at a suitable rate to periodically reverse the direction of the gravity-driven flow 132. In other words, the holder may be tilted in one direction to drive fluid from reservoir 64a to 64b in each vessel 50, and then tilted in the opposite rotational direction to drive fluid from reservoir 64b to 64a in each vessel 50, via channels 68a, 68b.

[0063] FIG. 18 shows another strip 140 during the culture of organoids 52 in the chamber 54. The strip 140 is similar to the strip 130 of FIGS. 16 and 17, in which flow 132 was driven between the channels 68a, 68b of each container 50. However, a separate channel 142 provides fluid communication between each pair of adjacent containers 50. More specifically, each channel 142 allows fluid to flow directly from the reservoir 64a of one container 50 to the reservoir 64b of the adjacent container 50, or vice versa, as indicated by flow arrows 144. To maintain fluid circulation, the strip 140 can be periodically tilted (as in FIG. 18) to drive fluid from left to right toward one end of the holder, and then tilted in the opposite rotational direction to drive fluid from right to left toward the opposite end of the holder. A pump 146 may transfer medium between reservoirs 64a, 64b located at opposite ends of strip 140, as indicated by flow arrows at 148. The pump can be used instead of or in addition to periodically tilting strip 140.

[0064] (Example 3) Container embodiment This example describes an exemplary embodiment 150 of container 50 of Section I having a container body 78 formed by injection molding and defining four reservoirs 64a-64d. See Figures 19-25.

[0065] Each reservoir 64a-64d may be in fluid communication with the receptacle 82 (and / or chamber 54) via a corresponding channel 68a-68d extending through the top wall 58 of the receptacle 82 (and / or chamber 54) (see Figures 23 and 25). The upper end of each channel may be flush with the top wall 58 (see Figure 25).

[0066] Various optical windows may be incorporated into the container 150. A planar seal member 80 (e.g., similar to a microscope cover slip) may provide a bottom window 88 for the chamber 54 after the seal member is adhered to the bottom end surface 152 of the container body 78 (see FIG. 21). The container body may include a pair of side windows 90 (see FIGS. 19-21), which may be angled slightly from vertical (see FIG. 24) to facilitate manufacture by injection molding.

[0067] (Example 4) Container with tube This example describes an exemplary vessel having tubes that are pre-formed and / or formed in situ, see Figures 26 and 27.

[0068] Figure 26 shows another embodiment 160 of container 50 for comparison with container 150 of Figure 25. Channels 68a-68d of container 160 differ from those of container 150. More specifically, channels 68b and 68c are defined in part by an annular protrusion 162 that protrudes from a bottom side of top wall 58 of receptacle 82 (and / or chamber 54). The lumens of any or all of the channels may be at least partially formed by the annular protrusion.

[0069] FIG. 27 illustrates laterally porous tubular extensions 164 that may be formed in situ on one or more annular projections 162 by 3D printing. Each tubular extension may or may not be branched. In the depicted embodiment, tubular extensions 164 interconnect channels 68b and 68c. In other embodiments, a porous tubular network may be formed that may interconnect any suitable subset or all of the channels. Each tubular extension 164 may be supported by and / or embedded in hydrogel 92 (see Section II). The tubular extensions may have the same composition as the hydrogel or may have a different composition, for example, to minimize / encourage cell attachment and / or remodeling, among others.

[0070] (Example 5) Container with electromagnet This example describes an exemplary embodiment 170 of vessel 50 having an electromagnet 172 positioned to attract ferromagnetically labeled cells 174 when the electromagnet is energized (i.e., turned on). See Figures 28-30.

[0071] Vessel 170 may be constructed similarly to vessel 150 and may have any suitable combination of vessel features disclosed herein (see FIG. 28). Electromagnet 172 may have a working end 176 located in close proximity to or within receptacle 82 and / or chamber 54 proximate at least one of channels 64a-64d. In the depicted embodiment, working end 176 is centered between channels 64b and 64c. The electromagnet may be energized through its top end 178.

[0072] 29 and 30 illustrate how an electromagnet 172 may be utilized to attract ferromagnetically labeled cells 174 to the hydrogel 92 and / or scaffold 86 in the chamber 54. The scaffold 86 and hydrogel 92 may be formed as described above. The ferromagnetically labeled cells 174 may be introduced into the receptacle with the medium 56 before the receptacle is sealed to form the chamber 54 or after sealing from one or more overlying reservoirs via one or more channels 68a-68d. In either case, the ferromagnetically labeled cells 174 may initially be outside the hydrogel 92 and settle in the bottom chamber 54, as in FIG. 29, before the electromagnet is turned on. FIG. 30 illustrates how energizing the electromagnet attracts the ferromagnetically labeled cells 174 to and / or into the scaffold 86. Ferromagnetically labeled cells may be associated with a ferromagnetic material (e.g., a compound containing iron, cobalt, and / or nickel, among others) before the cells are introduced into the receptacle / chamber. For example, the cells may be supplemented with ferromagnetic particles (such as iron oxide particles) to render the cells ferromagnetic, or may be coated with a ferromagnetic probe, among others.

[0073] Example 6: Rack for Reservoir Modules This example describes exemplary racks 180, 182 for holding containers 150 in a linear or two-dimensional array, respectively, to form strips 130. See Figures 31-34.

[0074] Each rack 180, 182 (interchangeably referred to as a holder) has a series of openings 184 for receiving the container bodies 78 of the containers 150. The openings 184 may be arranged along the same lines (rack 180) or in a rectangular grid pattern (rack 182), among others. Each container body 78 may be removably installed within the openings 184. The openings may be sized and shaped to prevent the container bodies from passing completely through the openings. The container bodies may be coupled to the openings 184 by any suitable mechanism, including snap fits or separate retention devices, among others.

[0075] Example 7: Container with access tube This example illustrates an exemplary container including an access tube and the use of the access tube to receive various instruments. See Figures 35-51.

[0076] FIG. 35 shows an embodiment 190 of the container 50 including a container body 78 sealed at its bottom end with a sealing member 80 to form a chamber 54. The container body 78 is similar to that described above with respect to the container 160 (see FIG. 26), except that the container body defines at least one access tube 192. The access tube may have a bottom end that is open at its top end 194 but closed by a barrier 196. The barrier may be a wall region of the upper wall 58 of the chamber that is shared between the access tube 192 and the chamber 54 and prevents fluid communication between the access tube and the chamber while the barrier is intact. The chamber 54 and the reservoirs 64a, 64b are not shown as containing a fluid (e.g., medium or other liquid) in any of the figures of Example 7 to simplify the drawings.

[0077] The barrier 196 may be configured to be breached by a sharp or blunt instrument to access the chamber 54, as described further below. Thus, the barrier may be thinner than adjacent regions of the upper wall 58, as shown in FIG. 35, and / or may include a predetermined structure (e.g., a predetermined frangible region of lesser thickness) that allows the barrier to be preferentially torn or otherwise breached with a suitable instrument.

[0078] FIG. 35 shows an exemplary instrument 198 inserted into the access tube 192. Here, the instrument 198 is a permanent magnet 200 with a pole 202 of the magnet adjacent to the barrier 196. In other embodiments, the magnet can be an electromagnet or any of the other instruments disclosed herein. The magnet 200 can be strong enough to form a magnetic field that extends into the chamber 54 while the barrier 196 is intact. In other cases, the bottom end of the magnet 200 can be inserted into the chamber 54 after the barrier 196 has been breached (and may even breach the barrier). Whether the magnet enters the chamber 54 or not, the magnet can apply an attractive force to ferromagnetic items (e.g., ferromagnetically labeled cells) inside the chamber 54. The magnet can be retractable / removable and / or rigidly attached to the access tube 192.

[0079] FIG. 36 shows the resulting container 190 with the organoids 52 present in the chamber 54 and the magnet 200 replaced by an instrument 198 structured as a needle 204 (compared to FIG. 35). The sharp tip 206 of the needle 204 pierces the barrier 196 (herein referred to as the breached barrier 196') and enters the organoids 52. The needle can be hollow or solid. In either case, the needle can allow a sample of the organoids 52 to be collected and removed from the chamber 54 via the access tube 192 for organoid biopsy. Alternatively or in addition, the needle can be used to introduce fluids, cells, and / or agents, among others, into the organoids 52 and the chamber 54. For example, the needle can allow tissue or cells to be transplanted into the organoids to achieve xenografts, autografts, or allografts.

[0080] FIG. 37 shows a container 190 as in FIG. 36, but the instrument 198 is a sensor / electrode 208 including an electrical connector 210 (e.g., one or more conductive wires). The sensing / stimulating end region 212 of the sensor / electrode 208 pierces the barrier 196 (herein referred to as the breached barrier 196') and enters the organoid 52. In other embodiments, the barrier 196 may first be breached by a different instrument 198, such as a dedicated breaching instrument, and then replaced by the sensor / electrode 208 (or any of the other instruments disclosed herein, among others). The sensor / electrode 208 may include at least one electrode or an array of electrodes for electrical stimulation of the organoid 52. Alternatively or in addition, the sensor / electrode 208 may include any suitable sensor, such as an electrical sensor (e.g., a capacitance sensor), a pH sensor for measuring pH, an electrochemical sensor, an oxygen sensor, a CO2 sensor, and / or the like.

[0081] 38-40 show the instrument 198 structured as a breaching instrument 214 before, during, and after the barrier 196 at the bottom end of the access tube 192 is punctured. In FIG. 38, the tip 216 of the breaching instrument 214 is traveling downward, indicated by the motion arrow at 218, nearly reaching the barrier 196. In FIG. 39, the tip 216 is in contact with the barrier 196 and applies a deformation force to the barrier. In FIG. 40, the tip 216 has passed completely through the barrier and entered the chamber 54. The wall region forming the barrier 196 may be sufficiently elastic to maintain radial contact with the breaching instrument 214 after the barrier is punctured. This radial contact may form a fluid-tight seal 220 between the container body 78 (at the breached barrier 216′) and the breaching instrument 214, which may substantially prevent fluid in the chamber 54 from traveling upward into the access tube 192.

[0082] The vessel 190 may have only one or more access tubes 192. For example, FIG. 41 shows the vessel 190 generally compartmentalized as in FIG. 24 such that three access tubes 192 are visible. Each access tube 192 may terminate in a separate barrier 196, as described above. Additionally, each barrier 196 may be a wall region of the top wall 58 intermediate and / or shared between the corresponding access tube 192 and the chamber 54. Thus, the wall region may or may not be a common wall region. In the depicted embodiment, a separate breaching instrument 214 is disposed in each of the three access tubes 192, with only one of the breaching instruments extending into the chamber 54. (The breached barrier is shown at 196′.) In other embodiments, any suitable number of barriers 196 may be breached to provide access to the chamber 54 using any suitable combination of instruments 198.

[0083] 42-44 show partial cross-sectional views of a different embodiment 230 of the container 50, taken as in FIGS. 38-40, before, during, and after the barrier 196 is breached with the breaching instrument 214. The barrier 196 of the container 230 has a frangible web 232 that causes the barrier to preferentially tear in response to pressure applied by the breaching instrument 214. In FIG. 44, the end of the breaching instrument 214 has entered the chamber 54. Fluid may proceed from the chamber 54 upwardly into the access tube 192, or the fluid may be restricted by, among other things, the close radial fit of the breaching instrument 214 with the access tube 192 and / or the hermetic seal around the breaching instrument at the top of the access tube 192.

[0084] 45 shows a vessel 190 with an attenuated total reflection (ATR) fiber optic probe 234 disposed within an access tube 192 and extending into the organoids 52 within the chamber 54. The ATR probe 234 has an illumination fiber 236, shown at 238, for directing light from a light source to the bottom end of the probe 234, and a sensor fiber 240, shown at 242, for directing light from the bottom end to an optical sensor (e.g., a spectrometer, photometer, or the like). The probe 234 may allow for IR spectroscopy (e.g., for chemical analysis of the organoids), Raman spectroscopy (such as surface-enhanced Raman spectroscopy), or the like.

[0085] 46 shows a vessel 190 with a fiber optic imaging probe 244 disposed within an access tube 192 and extending into the organoids 52 within the chamber 54. The imaging probe 244 may have an endoscopic front lens 246 and a fiber bundle 248 for the propagation of light from the front lens 246 to an image sensor. The imaging probe may allow, among other things, endoscopic imaging, confocal imaging, and / or only illumination (e.g., for imaging with an image sensor not coupled to the fiber bundle 248, optogenetics, etc.).

[0086] 47 shows a container 190 with an illumination device 250 disposed within an access tube 192 and extending into the organoids 52 within the chamber 54. The illumination device 250 may include an optical fiber 252 for directing light from a light source 254 to an exit aperture 256 at a distal end of the optical fiber 252. Exemplary uses for the illumination device 250 include illuminating the organoids 52 for imaging with an image sensor not coupled to the optical fiber 252, as a light source for wavefront sensing (adaptive optics), as a light source for optogenetics, etc.

[0087] FIG. 48 shows a container 190 with a pneumatic device 258 located within an access tube 192. The pneumatic device 258 has an expandable balloon 260 located inside the organoid 52. The balloon is operably connected to a pressure modulation device, such as a pump 262, which can inflate the balloon 260 and generate an internal mechanical strain on the organoid 52, shown at 264. The pneumatic device 258 can inflate and deflate the balloon 260, expanding and contracting it as needed. The balloon 260 may be printed with the scaffold 86 and later connected to the tube 266 of the pneumatic device 258. In other embodiments, the balloon 260 may be introduced into the organoid 52 via a needle or other sharp object.

[0088] Figure 49 shows a container 190 as in Figure 41, but with a pair of pneumatic devices 258a, 258b disposed within separate access tubes 192. The pneumatic devices are similar to those in Figure 48, except that each has an expandable balloon 260 positioned outside the organoids 52 to create an external mechanical strain on opposite sides of the organoids.

[0089] Figures 50 and 51 show the vessel 190 as viewed in Figures 35 and 36, respectively, but with a pair of mounted magnets 270a, 270b extending into the chamber 54 via corresponding access tubes 192. The magnets 270a, 270b magnetically attract individual magnets 272a, 272b that are already attached to a prefabricated scaffold structure 274 or biochip via magnetic forces.

[0090] Example 8: Container with flexible membrane This example describes an exemplary vessel 190 that utilizes one or more flexible membranes (interchangeably referred to as diaphragms) to drive fluid flow within the vessel. See Figures 52 and 53.

[0091] The container 190 includes a cap 282 that is mounted over the top of the container body 78. The cap 282 forms a hermetic seal with the container body 78. The cap includes a frame 284 that fits tightly over the top edge of the container body 78. At least one flexible membrane 286 is mounted to the frame 284 and covers at least two reservoirs (e.g., 64a, 64b). The undeformed configuration of the flexible membrane is shown in dashed lines at 288. A pressure 290 can be applied to the flexible membrane 286 across the reservoirs 64a or 64b to push the membrane down, shown at 292. This pressure drives fluid from one reservoir to the other through the chamber 54, shown by arrows 294, 296. The flexible membrane 286 may deflect upward, shown by 298, in response. Pressure may alternatively be applied to a flexible membrane 286 across the reservoirs 64a, 64b, as shown in Figures 52 and 53, to drive fluid in opposite directions between the reservoirs.

[0092] Example 9: Selected embodiments This example describes selected embodiments of the present disclosure as a series of indexed paragraphs.

[0093] Paragraph A1. A method of organoid culture and / or analysis, comprising: (a) sealing an open side of a receptacle to generate a chamber; and (b) forming an organoid within the chamber.

[0094] Paragraph A2. The method of paragraph A1, wherein the sealing step includes attaching a sealing member to the open side of the receptacle.

[0095] Paragraph A3. The method of paragraph A2, wherein attaching the seal member includes adhering the seal member to the receptacle.

[0096] Paragraph A4. The method of paragraph A3, wherein the adhering step includes adhering a prefabricated seal member to the receptacle.

[0097] Paragraph A5. The method of paragraph A2 or A3, wherein the sealing step includes hardening / solidifying a seal material at least partially within the receptacle to form a seal member.

[0098] Paragraph A6. The method of paragraph A5, wherein the sealing material includes a thermosetting resin.

[0099] Paragraph A7. The method of paragraph A6, wherein the sealing step includes forming a layer of thermosetting resin in the receptacle, irradiating the layer of thermosetting resin with electromagnetic radiation, such as ultraviolet light, and curing the thermosetting resin.

[0100] Paragraph A8. The method of paragraph A7, wherein the receptacle contains a scaffold for promoting organoid formation and the irradiating step is carried out using a sheet of light positioned and oriented to preferentially irradiate a layer of thermosetting resin relative to the scaffold.

[0101] Paragraph A9. The method of paragraph A7, wherein the receptacle contains a scaffold for promoting organoid formation and also contains a layer of thermosetting resin and a light-blocking layer coinciding with the middle of the scaffold, and the irradiating step is performed such that light propagates through the layer of thermosetting resin to the light-blocking layer, which substantially shields the scaffold from light.

[0102] Paragraph A10. The method of any of paragraphs A7-A9, wherein the step of forming a layer of thermosetting resin includes depositing the thermosetting resin on the hydrogel located in the receptacle using a 3D printer.

[0103] Paragraph A11. The method of paragraph A10, wherein the hydrogel comprises a scaffold for supporting organoid formation.

[0104] Paragraph A12. The method of paragraph A11, wherein the hydrogel comprises a first hydrogel for promoting organoid formation and a second hydrogel for temporarily supporting the layer of thermosetting resin, the second hydrogel being configured to substantially melt or dissolve when the chamber is used for organoid culture.

[0105] Paragraph A13. The method of any of paragraphs A1-A3 and A5, wherein the receptacle contains a scaffold for encouraging organoid formation, and the sealing step includes the steps of forming a layer of thermoplastic material over a hydrogel containing the scaffold, and hardening the layer of thermoplastic material by cooling and hermetically sealing the open side of the receptacle.

[0106] Paragraph A14. The method of any of paragraphs A1-A13, wherein the receptacle is defined by a container body and the sealing step includes attaching a sealing member to a bottom end of the container body.

[0107] Paragraph A15. The method of any of paragraphs A1-A14, wherein the method further comprises introducing a fluid and / or at least one substance from an overlying reservoir into the chamber (for contact with the organoid), and optionally, the chamber and the overlying reservoir are integrally formed with one another.

[0108] Paragraph A16. The method of paragraph A15, wherein the introducing step includes passing the fluid and / or at least one substance into the chamber via a channel extending from an overlying reservoir to the chamber, optionally the channel being integrally formed with the overlying reservoir and the chamber.

[0109] Paragraph A17. The method of paragraph A15 or A16, wherein the introducing step includes a step of passing nutrients through an upper wall of the chamber to supply the organoids.

[0110] Paragraph A18. The method of any of paragraphs A15-A17, wherein the introducing step includes passing a label through an upper wall of the chamber to label at least a portion of the organoid.

[0111] Paragraph A19. The step to be introduced is: (i) passing one or more agents through a top wall of the chamber, the one or more agents being selected from the group consisting of differentiation factors, growth factors, anti-cancer compounds, expression vectors, viruses, oligonucleotides, messenger RNA, and small interfering RNA; and / or (ii) passing a molecule through the top wall of the chamber, the molecule being configured for genome editing of the organoid (e.g., deleting, inserting, or substituting one or more nucleotides of a target sequence in cells of the organoid), such as genome editing using a CRISPR-Cas system, a TALEN system, or equivalent; and / or (iii) modifying the expression of one or more genes by passing a molecule through the top wall of the chamber to label and / or bind to one or more genomic loci of the organoid in vivo, the molecule being based on the CRISPR-Cas system, the TALEN system, or equivalent; The method of any of paragraphs A15-A18, comprising:

[0112] The molecules of (ii) or (iii) above may comprise any combination of guide RNA, effector molecules for CRISPR-Cas expression, viruses containing guide RNA and / or expression vectors for CRISPR-Cas system proteins, or CRISPR-Cas proteins.

[0113] Paragraph A20. The method of any of paragraphs A15 or A19, wherein the introducing step includes passing one or more solidifying and / or clarifying agents through a top wall of the chamber.

[0114] Paragraph A21. The method of any of paragraphs A15-A20, wherein the introducing step includes using gravity to drive the fluid from the reservoir into the chamber.

[0115] Paragraph A22. The method of any of paragraphs A15-A21, wherein the introducing step includes driving the fluid from an inlet to an outlet of the chamber, the inlet and outlet each comprising a separate channel extending through a top wall of the chamber.

[0116] Paragraph A23. The method of any of paragraphs A15-A22, wherein the chamber is separately fluidly connected to the first and second overlying reservoirs, and the introducing step includes introducing fluid and / or at least one substance into the chamber from each of the first and second overlying reservoirs.

[0117] Paragraph A24. The method of paragraph A23, wherein the organoid defines an interior space located inside the organoid within the chamber and an exterior space located outside the organoid, and wherein fluid retained by a first overlying reservoir is supplied to the interior space and fluid retained by a second overlying reservoir is supplied to the exterior space.

[0118] Paragraph A25. The method of any of paragraphs A15-A24, wherein the chamber is in separate fluid communication with the first and second overlying reservoirs, and the method further includes using a pump to transfer fluid from the second reservoir to the first reservoir and facilitating gravity-driven flow from the first reservoir to the second reservoir through the chamber.

[0119] Paragraph A26. The method of paragraph A25, wherein the pump transfers fluid from the second reservoir to the first reservoir at a rate that substantially matches a rate of gravity-driven flow.

[0120] Paragraph A27. The method of paragraph A26, wherein the chamber is separately fluidly connected to first and second overlying reservoirs defined by the container body, and the method further includes tilting the container body back and forth to produce alternating gravity-driven flow from the first reservoir to the second reservoir and from the second reservoir to the first reservoir.

[0121] Paragraph A28. The method of any of paragraphs A15-A27, wherein the first and second reservoirs are fluidly connected to the chamber via respective first and second channels, and the first and second reservoirs are directly fluidly connected to each other via a third channel above and spaced from the upper wall of the chamber.

[0122] Paragraph A29. The method of any of paragraphs A15-A28, wherein the first reservoir and the second reservoir overlie the chamber and are in separate fluid communication with the chamber, the method further including the steps of positioning a flexible membrane over the first reservoir and applying pressure to an upper side of the flexible membrane to drive fluid from the first reservoir through the chamber to the second reservoir.

[0123] Paragraph A30. The method of paragraph A29, wherein the step of positioning a flexible membrane includes the step of positioning a flexible membrane over each of the first and second reservoirs, and the step of applying pressure includes the step of alternately applying pressure to an upper side of the flexible membrane over the first reservoir and to an upper side of the flexible membrane over the second reservoir, alternatively driving fluid between the first and second reservoirs in opposite directions.

[0124] Paragraph A31. The method of any of paragraphs A1-A30, further comprising placing a scaffold inside the receptacle before the open side of the receptacle is sealed, the scaffold being configured to promote organoid formation.

[0125] Paragraph A32. The method of paragraph A31, wherein the step of positioning the scaffolding includes the step of generating the scaffolding inside the receptacle.

[0126] Paragraph A33. The method of paragraph A31, wherein the step of positioning the scaffolding includes placing a prefabricated scaffolding into the receptacle.

[0127] Paragraph A34. The method of any of paragraphs A31-A33, further comprising the step of introducing biological cells into the receptacle before the open side of the receptacle is sealed.

[0128] Paragraph A35. The method of Paragraph A34, wherein the biological cells include stem cells.

[0129] Paragraph A36. The method of paragraph A34 or A35, wherein the biological cells are introduced into the scaffold as the scaffold is generated.

[0130] Paragraph A37. The method of any of paragraphs A32 and A34-A36, wherein the step of generating the scaffold is carried out by 3D printing.

[0131] Paragraph A38. The method of paragraph A37, wherein generating the scaffold includes 3D printing at least two different hydrogels within the receptacle.

[0132] Paragraph A39. The method of paragraph A38, wherein at least one of the hydrogels contains cells to provide a custom-shaped 3D scaffold that, once 3D printed, encourages the formation of specific organoids.

[0133] Paragraph A40. The method of any of paragraphs A31-A39, wherein the receptacle has a wall opposite the open side and the scaffolding is attached to the wall.

[0134] Paragraph A41. The method of any of paragraphs A31-A40, further comprising the step of introducing biological cells for forming organoids into the chamber after the open side of the receptacle is sealed to generate the chamber.

[0135] Paragraph A42. The method of any of paragraphs A31-A41, wherein the chamber has an upper wall and the organoids, when formed, are supported by the upper wall.

[0136] Paragraph A43. The method of any of paragraphs A31-A42, wherein the chamber is fluidly connected to a plurality of overlying reservoirs via channels, and the method further includes generating an extension of one or more of the channels by 3D printing, and optionally embedding the extension in a hydrogel.

[0137] Paragraph A44. The method of paragraph A43, further comprising the step of extending and branching each extension by 3D printing to generate one or more laterally permeable tubes for supplying substances to cells inside the hydrogel.

[0138] Paragraph A45. The method of paragraph A44, further comprising the step of supplying one or more agents via one or more laterally permeable tubes to establish one or more concentration gradients of the agents inside the chamber for more controlled stem cell differentiation and organoid formation.

[0139] Paragraph A46. The method of any of Paragraphs A43-A45, further comprising incorporating polymeric or metallic microtubules into the hydrogel to promote fluid flow.

[0140] Paragraph A47. The method of any of paragraphs A1-A46, wherein the method further includes a step of collecting data relating to the organoids while the organoids remain in the chamber.

[0141] Paragraph A48. The method of paragraph A47, wherein the step of collecting data includes a step of capturing an image of at least a portion of the organoid.

[0142] Paragraph A49. The method of paragraph A48, wherein the capturing step includes capturing the image by light sheet microscopy.

[0143] Paragraph A50. The method of paragraph A48 or A49, wherein the capturing step includes detecting photoluminescence from the organoid.

[0144] Paragraph A51. The method of any of paragraphs A48-A50, wherein the capturing step includes capturing a stack of images representing a 3D structure of at least a portion of the organoid.

[0145] Paragraph A52. The method of paragraph A51, wherein the capturing step includes illuminating at least a portion of the organoid through a side window of the chamber and detecting optical radiation propagated out of the chamber through a bottom window of the chamber, or vice versa.

[0146] Paragraph A53. The method of any of paragraphs A47-A52, wherein collecting data includes chemically analyzing fluid from the chamber or overlying compartment for an analyte.

[0147] Paragraph A54. The method of any of paragraphs A47-A53, wherein the step of collecting data is performed using a sensor located at least partially inside the chamber.

[0148] Paragraph A55. The method of any of paragraphs A47-A54, wherein collecting data includes collecting data from cells and / or fluids that are removed from the chamber while its bottom remains sealed.

[0149] Paragraph A56. The method of paragraph A55, wherein the step of collecting data includes the step of forming an opening in an upper wall of the chamber and the step of removing cells and / or fluid from the chamber through the opening.

[0150] Paragraph A57. The method of any of Paragraphs A1-A56, wherein the method further includes creating an opening in a wall of the chamber and inserting an end of an instrument into the chamber through the opening.

[0151] Paragraph A58. The method of paragraph A57, wherein the multiple overlying compartments share a common wall with the chamber, and an opening is created in the common wall at a bottom end of one of the overlying compartments.

[0152] Paragraph A59. The method of paragraph A58, wherein the multiple overlying compartments include multiple reservoirs and one or more access tubes, and the opening is created in a bottom end of one of the access tubes.

[0153] Paragraph A60. The method of paragraph A58 or A59, wherein the opening is created using an instrument, and creating the opening includes breaking through the common wall with an end of the instrument.

[0154] Paragraph A61. The method of any of paragraphs A57-A60, wherein the end of the instrument is a sharp end.

[0155] Paragraph A62. The method of paragraph A60 or A61, wherein creating the opening includes forming a fluid-tight seal between the instrument and a common wall at the opening.

[0156] Paragraph A63. The method of any of paragraphs A60-A62, wherein the common wall defines a feature such that the common wall is configured such that it is torn by mechanical pressure exerted on the common wall via an instrument.

[0157] Paragraph A64. The method of any of paragraphs A57-A63, wherein the instrument is selected from the group consisting of a needle, a light guide operably connected to a light source, an endoscope, an electrode, an ATR probe, an air / hydraulic source optionally coupled to a balloon, and a magnet.

[0158] Paragraph A65. The method of any of paragraphs A57-A64, wherein the instrument includes a sensor located at an end thereof.

[0159] Paragraph A66. The method of paragraph A65, further comprising sensing a parameter of the chamber and / or the organoid using a sensor.

[0160] Paragraph A67. The method of any of Paragraphs A57-A66, wherein the apparatus includes an electrode configured to electrically stimulate the organoid.

[0161] Paragraph A68. The method of paragraph A67, wherein the method further comprises electrically stimulating the organoid using electrodes.

[0162] Paragraph A69. The method of any of Paragraphs A57-A68, wherein the instrument includes a light guide optically coupled to the light source and having an opening at an end that introduces into the chamber.

[0163] Paragraph A70. The method of any of Paragraphs A57-A69, wherein the instrument includes a magnet located at an end that is introduced into the chamber.

[0164] Paragraph A71. The method of any of Paragraphs A57-A70, wherein the instrument includes an attenuated total reflectance (ATR) probe.

[0165] Paragraph A72. The method of any of Paragraphs A57-A71, wherein the instrument includes an endoscope.

[0166] Paragraph A73. The method of any of paragraphs A57-A72, wherein the instrument is coupled to a pneumatic or hydraulic source.

[0167] Paragraph A74. The method of any of Paragraphs A1-A73, further comprising introducing a test compound into the chamber.

[0168] Paragraph A75. The method of any of Paragraphs A1-A74, wherein the method includes forming a plurality of organoids in a corresponding plurality of chambers.

[0169] Paragraph A76. The method of paragraph A75, further comprising applying a different treatment to each of the organoids.

[0170] Paragraph A77. The method of Paragraph A76, wherein the step of applying a different treatment comprises introducing a different test compound into each chamber of the plurality of chambers.

[0171] Paragraph A78. The method of Paragraph A77, wherein each different test compound is a potential anti-cancer agent.

[0172] Paragraph A79. The method of any of Paragraphs A76-A78, further comprising the step of introducing one or more cells, optionally cancer cells, into each of the chambers.

[0173] Paragraph A80. The method of paragraph A79, wherein the one or more cells are optionally introduced into the organoids in the chamber via a needle, optionally wherein the needle pierces a top wall of the chamber.

[0174] Paragraph A81. The method of any of Paragraphs A76-A80, further comprising collecting data for each organoid of the plurality of organoids and testing different treatments for an effect on the organoids.

[0175] Paragraph A82. The method of paragraph A81, wherein the step of collecting data includes a step of imaging each organoid in situ within its individual chamber.

[0176] Paragraph A83. The method of paragraph A81 or A82, wherein the step of collecting data includes a step of chemically analyzing individual fluids associated with each organoid for an analyte.

[0177] Paragraph A84. The method of any of paragraphs A81-A83, wherein the step of collecting data optionally includes removing each organoid from its chamber after removing the sealing member.

[0178] Paragraph A85. The method of paragraph A84, wherein collecting data includes imaging each organoid after removal from its chamber.

[0179] Paragraph A86. The method of paragraph A85, wherein the step of collecting data includes physically sectioning each organoid after removal from its chamber, and optionally imaging a plurality of sections produced by the physical sectioning.

[0180] Paragraph B1. A method for organoid culture and / or analysis, comprising: (a) forming organoids inside a chamber, wherein an access tube covers the top of the chamber and a bottom end of the access tube is closed by a top wall region of the chamber; (b) supplying nutrients to the chamber to replenish the organoids; (c) forming an opening through the top wall region; and (d) inserting an end of an instrument into the chamber through the access tube.

[0181] Paragraph C1. A method of organoid culture and / or analysis comprising: (a) sealing an open side of a receptacle to generate a chamber; (b) forming an organoid inside the chamber; (c) supplying a substance / fluid to the chamber; and (d) capturing an image of at least a portion of the organoid while the organoid remains enclosed by the walls of the chamber.

[0182] Paragraph D1. A device for culturing and / or analyzing organized multicellular structures (e.g., organoids), comprising: (a) a body defining a receptacle and at least two reservoirs, the at least two reservoirs overlying the receptacle and separately in fluid communication with the receptacle via separate channels; and (b) a sealing member adhered or adhereable to the body on an open side of the receptacle to create a chamber for the multicellular structure.

[0183] Paragraph D2. The device of paragraph D1, further comprising a scaffold for biological cells attached to the wall of the receptacle.

[0184] Paragraph D3. The device of paragraph D2, wherein the scaffold is included in a hydrogel.

[0185] Paragraph D4. The device of Paragraph D3, wherein the hydrogel contains biological cells.

[0186] Paragraph D5. The device of Paragraph D4, wherein the biological cells include stem cells.

[0187] Paragraph D6. The device of any of paragraphs D3-D5, wherein the hydrogel contains a deposit of a drug.

[0188] Paragraph D7. The device of paragraph D6, wherein the deposit can be opened by light-induced release to release the drug from the deposit.

[0189] Paragraph D8. The device of any of paragraphs D1-D7, wherein the receptacle and the at least two reservoirs are integrally formed with one another.

[0190] Paragraph D9. The device of any of paragraphs D1-D8, wherein the body is injection molded as a single piece.

[0191] Paragraph D10. The device of any of paragraphs D1-D9, wherein each reservoir of the at least two reservoirs shares a wall with the receptacle.

[0192] Paragraph D11. The device of any of paragraphs D1-D10, wherein each channel extends through a wall intermediate, and optionally shared between, the corresponding reservoir and receptacle.

[0193] Paragraph D12. The device of any of paragraphs D1-D11, further comprising a removable lid configured to cover an open top of each reservoir of the at least two reservoirs.

[0194] Paragraph D13. The device of any of paragraphs D1-D12, wherein the device is in a sterile state.

[0195] Paragraph D14. The device of any of paragraphs D1-D13, wherein the seal member is bonded to the body.

[0196] Paragraph D15. The device of Paragraph D14, wherein the organoid is contained in a chamber.

[0197] Paragraph D16. The device of any of paragraphs D1-D15, wherein the body defines at least four reservoirs, each disposed in fluid communication with a receptacle.

[0198] Paragraph D17. The device of any of paragraphs D1-D16, wherein the sealing member is configured to provide a bottom window for imaging at least a portion of the organoid contained in the chamber.

[0199] Paragraph D18. The device of any of paragraphs D1-D17, wherein the body provides a pair of side windows and allows illumination of at least a portion of the organoids contained in the chamber through either one of the side windows.

[0200] Paragraph D19. The device of any of paragraphs D1-D18, wherein the body defines an access tube having an open top end and a closed bottom end, and a common wall separates the chamber from the bottom end of the tube.

[0201] Paragraph D20. The device of any of paragraphs D1-D19, further comprising a linear array of substantially identical units interconnected together, one of the units including a receptacle and at least two reservoirs.

[0202] The term "exemplary" as used in this disclosure means "illustrative" or "serving as an example." Similarly, the term "exemplary" means "to illustrate by giving an example." Neither term implies desirability or advantage.

[0203] The disclosure set forth above may encompass multiple distinct inventions with independent utility. Each of these inventions has been disclosed in its preferred form, but the specific embodiments thereof as disclosed and illustrated herein are not to be considered in a limiting sense, as numerous variations are possible. The subject matter of the invention includes all novel and unobvious combinations and subcombinations of the various elements, features, functions, and / or properties disclosed herein. The following claims specifically point out certain combinations and subcombinations that are considered novel and unobvious. Inventions embodied in other combinations and subcombinations of features, functions, elements, and / or properties may be claimed in applications claiming priority from this or related applications. Such claims, whether directed to different or the same invention, whether broader, narrower, equal, or different in scope to the original claims, are also considered to be included within the subject matter of the invention of the present disclosure. Furthermore, ordinal indicators such as first, second, or third with respect to identified elements are used to distinguish between the elements and do not indicate a particular position or order of such elements, unless specifically stated otherwise.

Claims

1. 1. A method of organoid culture, the method comprising: providing a receptacle defined by a top wall and a pair of side walls, the top wall having a first end and a second end, each of the pair of side walls having a first end and a second end, the first end of a first of the pair of side walls extending from the first end of the top wall, the first end of a second of the pair of side walls extending from the second end of the top wall, and the second end of the first of the pair of side walls and the second end of the second of the pair of side walls not contacting each other; positioning the receptacle and a reservoir integrally formed with the receptacle in an inverted position, the receptacle being disposed above the reservoir; placing a scaffold on the top wall of the receptacle; bonding a seal member to each of the second end of a first one of the pair of side walls of the receptacle and the second end of a second one of the pair of side walls of the receptacle to create a chamber; inverting the chamber and the reservoir such that the chamber is disposed below the reservoir; forming organoids in the chamber using the scaffold; A method comprising:

2. The method of claim 1, wherein the bonding includes bonding a prefabricated sealing member to the receptacle.

3. The method of claim 1, wherein the bonding includes forming the seal member by at least partially solidifying a seal material within the receptacle.

4. The method of claim 1, further comprising introducing a fluid and / or at least one substance into the chamber from the reservoir formed integrally with the receptacle.

5. The method of claim 1, wherein positioning the scaffolding includes 3D printing the scaffolding within the receptacle.

6. The method of claim 1, further comprising capturing an image of at least a portion of the organoid while the organoid is located within the chamber.

7. The method of claim 6, wherein the capturing includes capturing an image by light sheet microscopy.

8. 1. A method of organoid culture, the method comprising: providing a receptacle defined by a top wall and a pair of side walls, the top wall having a first end and a second end, each of the pair of side walls having a first end and a second end, the first end of a first of the pair of side walls extending from the first end of the top wall, the first end of a second of the pair of side walls extending from the second end of the top wall, and the second end of the first of the pair of side walls and the second end of the second of the pair of side walls not contacting each other; positioning the receptacle and a reservoir integrally formed with the receptacle in an inverted position, the receptacle being disposed above the reservoir; placing a scaffold on the top wall of the receptacle; attaching a sealing member to each of the second end of the first one of the pair of side walls of the receptacle and the second end of the second one of the pair of side walls of the receptacle to create a chamber; inverting the chamber and the reservoir such that the chamber is disposed below the reservoir; forming organoids in the chamber using the scaffold when the sealing member is attached to each of the second end of the first one of the pair of side walls of the receptacle and the second end of the second one of the pair of side walls of the receptacle; A method comprising:

9. The method of claim 8, wherein positioning the scaffolding includes 3D printing the scaffolding within the receptacle.

10. The method of claim 9, wherein the 3D printing includes incorporating stem cells into the scaffold.

11. The method of claim 8, wherein attaching the sealing member includes adhering the sealing member to each of the second end of the first one of the pair of side walls of the receptacle and the second end of the second one of the pair of side walls of the receptacle.

12. The method according to claim 1, creating an opening in a top wall of the chamber; inserting an end of an instrument through said opening and into said chamber; The method of claim 8 further comprising:

13. 13. The method of claim 12, wherein the instrument is selected from the group consisting of a needle, a light guide operably connected to a light source, an endoscope, an electrode, an ATR probe, a pneumatic / hydraulic source coupled to a balloon, and a magnet.

14. 1. A method of organoid culture, the method comprising: providing a receptacle defined by a top wall and a pair of side walls, the top wall having a first end and a second end, each of the pair of side walls having a first end and a second end, the first end of a first of the pair of side walls extending from the first end of the top wall, the first end of a second of the pair of side walls extending from the second end of the top wall, and the second end of the first of the pair of side walls and the second end of the second of the pair of side walls not contacting each other; positioning the receptacle and a reservoir integrally formed with the receptacle in an inverted position, the receptacle being disposed above the reservoir; placing a scaffold on the top wall of the receptacle; attaching a seal member to the second end of the first one of the pair of side walls of the receptacle and to the second end of the second one of the pair of side walls of the receptacle to create a chamber; inverting the chamber and the reservoir such that the chamber is disposed below the reservoir; forming organoids in the chamber using the scaffold; introducing a fluid and / or at least one substance from the reservoir integrally formed with the receptacle through the top wall into the chamber for contact with the organoids; A method comprising:

15. The method of claim 14, wherein the introducing comprises passing the fluid and / or the at least one substance into the chamber via a channel extending through a wall intermediate the reservoir and the chamber.

16. The method of claim 14, wherein the introducing includes replenishing the organoids by passing nutrients through an upper wall of the chamber.

17. The method of claim 14, wherein the introducing includes passing one or more solidifying and / or clarifying agents through an upper wall of the chamber.

18. The method of claim 14, wherein the introducing includes driving the fluid from the reservoir into the chamber using gravity.

19. The method of claim 14, wherein the introducing includes driving the fluid from an inlet to an outlet of the chamber, each of the inlet and the outlet including a channel extending through an upper wall of the chamber.

20. The method according to claim 1, forming a plurality of organoids in a corresponding plurality of chambers; applying a different treatment to each of the plurality of organoids; The method of claim 14 further comprising:

21. The method of claim 20, wherein applying the different treatments comprises introducing a different test compound into each chamber of the plurality of chambers.

22. The method of claim 20, wherein applying the different treatments includes modifying the genetic material of each organoid in its individual chamber by genome editing.

23. The method of claim 20, wherein applying the different treatments comprises in vivo labeling of at least one genomic locus or using one or more DNA binding agents to modify the gene expression profile of each organoid within its individual chamber.

24. The method of claim 20, further comprising testing the different treatments for their effect on the plurality of organoids by collecting data for each organoid of the plurality of organoids.

25. The method of claim 24, wherein collecting the data includes imaging each organoid in situ within its individual chamber.

26. The method of claim 24, wherein collecting the data includes chemically analyzing individual fluids associated with each organoid for analytes.

27. ​​The method of claim 24, wherein collecting the data includes removing each organoid from its chamber and collecting the data from the organoid after removal from its chamber.

28. The method of claim 27, wherein collecting the data includes physically sectioning each organoid after removal from its chamber.

29. 15. The method of claim 14, wherein a first reservoir and a second reservoir overlie and are in separate fluid communication with the chamber, the method further comprising: disposing a flexible membrane over the first reservoir; and driving the fluid from the first reservoir to the second reservoir through the chamber by applying pressure to an upper side of the flexible membrane.

Citation Information

Patent Citations

  • Method for producing lamination type high density cultured artificial tissue and lamination type high density cultured artificial tissue

    JP2010172247A

  • Micro-physiological organoid culture

    WO2019068640A1